NCT06935669View on ClinicalTrials.gov

Analgesic Effect of Bupivacaine Plus Ketamine Versus Bupivacaine Alone in Transversalis Fascia Plane Block

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 25, 2025

Primary Completion Date

April 25, 2026

Study Completion Date

May 15, 2026

Conditions
Analgesia
Interventions
DRUG

Ketamine

Patients in this group will receive a transversalis fascia plane block using a combination of bupivacaine and ketamine.

DRUG

Bupivacaine

Control group to evaluate the additional effect of ketamine in the experimental arm.

DRUG

Bupivacain

Patients in this group will receive a transversalis fascia plane block using a combination of bupivacaine and ketamine.

Trial Locations (1)

Unknown

Ain Shams University faculty of medicine, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER